日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Thin-diaPASEF: diaPASEF for maximizing proteome coverage in single-shot proteomics

Thin-diaPASEF:diaPASEF 用于在单次蛋白质组学中最大化蛋白质组覆盖率

Konno, Ryo; Ishikawa, Masaki; Nakajima, Daisuke; Inukai, Kaori; Ohara, Osamu; Kawashima, Yusuke

Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels

青蒿琥酯和顺铂协同抑制 HNSCC 细胞生长并促进细胞凋亡,青蒿琥酯诱导 Rb 和磷酸化 Rb 水平降低

Hiroki Okamoto, Kazuhiro Yoshikawa, Akiko Shimada, Rui Sano, Daisuke Inukai, Shunpei Yamanaka, Susumu Suzuki, Ryuzo Ueda, Hiromi Ueda, Yasushi Fujimoto, Tetsuya Ogawa

Immune-checkpoint molecules on regulatory T-cells as a potential therapeutic target in head and neck squamous cell cancers

免疫检查点分子在调节性T细胞上作为头颈部鳞状细胞癌的潜在治疗靶点

Susumu Suzuki ,Tetsuya Ogawa ,Rui Sano ,Taishi Takahara ,Daisuke Inukai ,Satou Akira ,Hiromi Tsuchida ,Kazuhiro Yoshikawa ,Ryuzo Ueda ,Toyonori Tsuzuki

Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines

通过整合头颈癌细胞系的转录组学和蛋白质组学数据来鉴定顺铂耐药因子

Daisuke Inukai, Kunihiro Nishimura, Hiroki Okamoto, Rui Sano, Hiromi Ueda, Akinobu Ota, Sivasundaram Karnan, Yoshitaka Hosokawa, Kazuhiro Yoshikawa, Susumu Suzuki, Ryuzo Ueda, Kenta Murotani, Carol R Bradford, Tetsuya Ogawa

Painless thyroiditis in a dupilumab-treated patient

接受度普利尤单抗治疗的患者出现无痛性甲状腺炎

Narantsatsral, Daramjav; Junko, Takagi; Hideyuki, Iwayama; Daisuke, Inukai; Hiroyuki, Takama; Yuka, Nomura; Syo, Hirase; Hiroyuki, Morita; Kazuo, Otake; Tetsuya, Ogawa; Akiyoshi, Takami